ID
15255
Beschrijving
A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00231634
Link
https://clinicaltrials.gov/show/NCT00231634
Trefwoorden
Versies (1)
- 23-05-16 23-05-16 -
Geüploaded op
23 mei 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Obesity NCT00231634
Eligibility Obesity NCT00231634
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
hypersensitivity to topiramate
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0076829
- UMLS CUI [1,3]
- C0020517
- UMLS CUI [2,1]
- C0038766
- UMLS CUI [2,2]
- C1301624
- UMLS CUI [2,3]
- C0020517
Beschrijving
pregnancy or nursing
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Beschrijving
type 1 diabetes
Datatype
boolean
Alias
- UMLS CUI [1]
- C0011854
Beschrijving
severe recurrent hypoglycemic episodes
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0020615
- UMLS CUI [1,2]
- C0205082
- UMLS CUI [1,3]
- C2945760
Beschrijving
antidiabetic agent
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0935929
- UMLS CUI [1,2]
- C0205394
Similar models
Eligibility Obesity NCT00231634
- StudyEvent: Eligibility
C0020473 (UMLS CUI [2,1])
C0742801 (UMLS CUI [2,2])
C1999124 (UMLS CUI [1,2])
C0076829 (UMLS CUI [1,2])
C0020517 (UMLS CUI [1,3])
C0038766 (UMLS CUI [2,1])
C1301624 (UMLS CUI [2,2])
C0020517 (UMLS CUI [2,3])
C0006147 (UMLS CUI [2])
C0205082 (UMLS CUI [1,2])
C2945760 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,2])